Ryan H. Siurek - 08 May 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Accounting Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Ryan H. Siurek
Issuer symbol
BDSX
Transactions as of
08 May 2023
Transactions value $
-$3,170
Form type
4
Filing time
10 May 2023, 20:16:23 UTC
Previous filing
03 Mar 2023
Next filing
18 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +5,484 +14.9% 42,288 08 May 2023 Direct F1, F2
transaction BDSX Common Stock Sale -$2,280 -1,456 -3.44% $1.57 40,832 09 May 2023 Direct F3, F4
transaction BDSX Common Stock Sale -$888 -564 -1.38% $1.58 40,268 10 May 2023 Direct F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -1,927 -8.33% $0 21,193 08 May 2023 Common Stock 1,927 Direct F1, F6
transaction BDSX Restricted Stock Units Options Exercise $0 -3,557 -50% $0 3,557 08 May 2023 Common Stock 3,557 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023.
F3 These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.
F4 The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F7 These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.